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GLANDS (> 250 GRAMS)
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Presented By: Jordan Krieger, MD, BS
Introduction: Prostatic artery embolization (PAE) has the ability to decrease blood supply to
the prostate and shrink the prostate, but it is unclear if PAE causes changes to the prostate
making surgical intervention on the prostate technically difficult. Our objective was to
evaluate if holmium laser enucleation of the prostate (HOLEP) could be performed efficiently
and safely after PAE for massive prostate glands (> 250 grams).
Methods: Patients with prostate glands over 250 grams on imaging (CT or MRI) and
symptomatic BPH were offered HOLEP with PAE ahead of time. Preoperative demographics
were evaluated along with PAE and HOLEP procedural times, enucleated volume and
postoperative complications.
Results: Nine patients had prostate glands >250 grams and underwent HOLEP with PAE
prior. Prostate size on pre-operative imaging was 290.3±38.5 grams and 6 (66%) patients
were catheter dependent prior to intervention. 8 (89%) patients underwent bilateral PAE
while one patient underwent unilateral PAE with a procedure time of 174.4±64.6 minutes.
HOLEP was successfully performed in all patients with procedural time of 159.4±48.5
minutes, enucleation time of 91.4±22.3 minutes, and enucleated volume of 130.8±41.5
grams. Enucleation efficiency was 1.43 grams per minute. All patients passed a void trial
on their first attempt after surgery. One patient required repeat surgery for morcellation of a
retained fragment.
Conclusion: HOLEP can be performed efficiently without increased complications after
PAE by an experienced surgeon. This is important as PAE has the potential to be an adjunct
treatment in massive prostate glands that are otherwise technically difficult to resect.
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Introduction: Segmental testicular infarction (STI) is a rare cause of acute scrotum of
unknown etiology. The diagnosis is often made by color Doppler ultrasonography (CDUS)
demonstrating absent perfusion in a well-defined testicular region. Previously patients
underwent surgical exploration, but currently conservative therapy is recommended.
Methods: We report a case of STI related to anabolic steroid use.
Results: A 44-year-old male with a history of hypertension presented to the emergency
room with acute, severe right testicular pain which was unprovoked and constant. Physical
exam was notable only for tenderness at the inferior right testicle. CDUS showed small
bilateral hydroceles but preserved blood flow (Figure 1A-B). Upon receiving analgesics
with moderate relief, he left AMA but returned the following day with unrelenting pain. Exam
was unchanged though repeat CDUS demonstrated a wedge of absent perfusion in the
inferior right testicle (Figure 1C-D). Serum tumor markers were normal, though patient
was polycythemic with a hemoglobin of 18.7 g/dL. On further questioning, patient revealed
that he takes anabolic steroids for body-building. He was admitted for pain control and
discharged two days later but unfortunately lost to follow up.
Conclusion: STI, once properly diagnosed, can be safely managed conservatively. Our
patient’s polycythemia, a consequence of exogenous testosterone, likely created a low-flow
state leading to STI.
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Presented By: Alexander Geisenhoff
Introduction: Excision and primary anastomosis (EPA) has been the gold standard
procedure for definitively managing short bulbar urethral strictures. A non-transecting
approach was developed to help preserve proximal blood supply of the urethra. The
previously described technique involves a dorsal urethrotomy and excision of the stricture
without disrupting the anterior spongiosum. We describe a novel approach by performing
a ventral urethrotomy leaving the posterior spongiosum intact. By not requiring urethral
rotation, we believe this technique is simpler and does not compromise outcomes.
Methods: Retrospective chart review was performed on 8 consecutive patients from April
2019 to February 2021 who underwent non-transecting EPA with ventral urethrotomy for
short bulbar urethral strictures. We reviewed demographics and when available pre and
postoperative data points including uroflow, post-void residuals, SHIM and AUA scores.
Results: All 8 patients underwent the aforementioned procedure. Average age was 48.6
years, and average stricture length was 1.375 cm. All 8 patients underwent postoperative
voiding cystourethrogram at 2 weeks which confirmed no contrast extravasation and no
residual stricture. We had a stricture free rate of 100% (8/8 cases) with median follow-up
time of 4 months (range 0-14 months). Average increase in Q-max was 14.2 mL/s.
Conclusion: Our case series demonstrates that non-transecting EPA with ventral
urethrotomy is a safe and effective alternative to dorsal urethrotomy for the management of
short bulbar urethral strictures with the added benefit of requiring less complexity.
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